Information Provided By:
Fly News Breaks for June 1, 2018
HUM
Jun 1, 2018 | 07:12 EDT
Citi analyst Ralph Giacobbe resumed coverage of Humana with a Buy rating and $340 price target. The analyst continues to see the company as well positioned in an "attractive" Medicare Advantage end market that has "broad demographic/structural tailwinds." This creates a solid long-term growth profile for Humana and makes the company a "coveted asset and providing valuation support in the least," Giacobbe tells investors in a research note.